Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer

Proteomics

Volumn 11, Issue 11, 2011, Pages 2162-2170

  Tsai, Hsien Yu ^a,b   Boonyapranai, Kongsak ^c   Sriyam, Supawadee ^c   Yu, Chong Jen ^d   Wu, Sz Wei ^e   Khoo, Kay Hooi ^a,b,e,f   Phutrakul, Suree ^c   Chen, Shui Tein ^a,b,f  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^c CHIANG MAI UNIVERSITY   (Thailand)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e NRPGM Core Facilities for Proteomics and Glycomics   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

Biomarker; Fucosylation; Glycan moiety; Glycoproteomics; Haptoglobin; Lung cancer

Indexed keywords

HAPTOGLOBIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; LUNG CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEOMICS;

ADULT; AGED; BLOTTING, WESTERN; CARBOHYDRATE CONFORMATION; CASE-CONTROL STUDIES; FUCOSE; GLYCOPROTEINS; HAPTOGLOBINS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; PEPTIDE FRAGMENTS; POLYSACCHARIDES; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TRYPSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 79956282745     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000319     Document Type: Article

References (37)

1. Travis, W. D., Travis, L. B., Devesa, S. S., Lung cancer. Cancer 1995, 75, 191-202.
2. Bharti, A., Ma, P. C., Salgia, R., Biomarker discovery in lung cancer--promises and challenges of clinical proteomics. Mass Spectrom. Rev. 2007, 26, 451-466.
3. Tubbs, K. A., Kiernan, U. A., Niederkofler, E. E., Nedelkov, D. et al., High-throughput MS-based protein phenotyping: application to haptoglobin. Proteomics 2005, 5, 5002-5007.
4. Buehler, P. W., Abraham, B., Vallelian, F., Linnemayr, C. et al., Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 2009, 113, 2578-2586.
5. Lau, K. S., Dennis, J. W., N-Glycans in cancer progression. Glycobiology 2008, 18, 750-760.
6. Kirmiz, C., Li, B., An, H. J., Clowers, B. H. et al., A serum glycomics approach to breast cancer biomarkers. Mol. Cell. Proteomics 2007, 6, 43-55.
7. Arnold, J. N., Saldova, R., Hamid, U. M., Rudd, P. M., Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 2008, 8, 3284-3293.
8. Comunale, M. A., Wang, M., Hafner, J., Krakover, J. et al., Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J. Proteome Res. 2009, 8, 595-602.
9. Misonou, Y., Shida, K., Korekane, H., Seki, Y. et al., Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells. J. Proteome Res. 2009, 8, 2290-2305.
10. Miyoshi, E., Nakano, M., Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures. Proteomics 2008, 8, 3257-3262.
11. Fujimura, T., Shinohara, Y., Tissot, B., Pang, P. C. et al., Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects. Int. J. Cancer 2008, 122, 39-49.
12. Ang, I. L., Poon, T. C., Lai, P. B., Chan, A. T. et al., Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. J. Proteome Res. 2006, 5, 2691-2700.
13. Hoagland, L. F. t., Campa, M. J., Gottlin, E. B., Herndon, J. E., 2nd, Patz, E. F., Jr, Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer. Cancer 2007, 110, 2260-2268.
14. Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T. et al., Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 2006, 118, 2803-2808.
15. Abd Hamid, U. M., Royle, L., Saldova, R., Radcliffe, C. M. et al., A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 2008, 18, 1105-1118.
16. Saldova, R., Royle, L., Radcliffe, C. M., Abd Hamid, U. M. et al., Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 2007, 17, 1344-1356.
17. Hongsachart, P., Huang-Liu, R., Sinchaikul, S., Pan, F. M. et al., Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma. Electrophoresis 2009, 30, 1-15.
18. Yu, S. Y., Wu, S. W., Khoo, K. H., Distinctive characteristics of MALDI-Q/TOF and TOF/TOF tandem mass spectrometry for sequencing of permethylated complex type N-glycans. Glycoconj. J. 2006, 23, 355-369.
19. He, Z., Aristoteli, L. P., Kritharides, L., Garner, B., HPLC analysis of discrete haptoglobin isoform N-linked oligosaccharides following 2D-PAGE isolation. Biochem. Biophys. Res. Commun. 2006, 343, 496-503.
20. Sekiya, S., Wada, Y., Tanaka, K., Derivatization for stabilizing sialic acids in MALDI-MS. Anal. Chem. 2005, 77, 4962-4968.
21. Alley, W. R., Jr, Novotny, M. V., Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins. J. Proteome Res. 2010, 9, 3062-3072.
22. Kramer, F., Torzewski, J., Kamenz, J., Veit, K. et al., Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaB- and C/EBPbeta-dependent autocrine interleukin-6 loop. Mol. Immunol. 2008, 45, 2678-2689.
23. Baumann, H., Jahreis, G. P., Morella, K. K., Interaction of cytokine- and glucocorticoid-response elements of acute-phase plasma protein genes. Importance of glucocorticoid receptor level and cell type for regulation of the elements from rat alpha 1-acid glycoprotein and beta-fibrinogen genes. J. Biol. Chem. 1990, 265, 22275-22281.
24. Narisada, M., Kawamoto, S., Kuwamoto, K., Moriwaki, K. et al., Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells. Biochem. Biophys. Res. Commun. 2008, 377, 792-796.
25. Yanagawa, H., Sone, S., Takahashi, Y., Haku, T. et al., Serum levels of interleukin 6 in patients with lung cancer. Br. J. Cancer 1995, 71, 1095-1098.
26. Steirer, L. M., Park, E. I., Townsend, R. R., Baenziger, J. U., The asialoglycoprotein receptor regulates levels of plasma glycoproteins terminating with sialic acid alpha2, 6-galactose. J. Biol. Chem. 2009, 284, 3777-3783.
27. Sato, T., Furukawa, K., Autero, M., Gahmberg, C. G., Kobata, A., Structural study of the sugar chains of human leukocyte common antigen CD45. Biochemistry 1993, 32, 12694-12704.
28. Tang, Z., Varghese, R. S., Bekesova, S., Loffredo, C. A. et al., Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. J. Proteome Res. 2010, 9, 104-112.
29. Asao, T., Yazawa, S., Nagamachi, Y., Abbas, S. A., Matta, K. L., Serum alpha(1----3)-L-fucosyltransferase, carcinoembryonic antigen, and sialyl Lewis X-i antigen levels in lung cancer. Cancer 1989, 64, 2541-2545.
30. Ogawa, J., Inoue, H., Koide, S., Expression of alpha-1, 3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer. Cancer Res. 1996, 56, 325-329.
31. Yazawa, S., Madiyalakan, R., Izawa, H., Asao, T. et al., Cancer-associated elevation of alpha(1----3)-L-fucosyltransferase activity in human serum. Cancer 1988, 62, 516-520.
32. Higai, K., Miyazaki, N., Azuma, Y., Matsumoto, K., Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene. FEBS Lett. 2006, 580, 6069-6075.
33. Jia, W., Lu, Z., Fu, Y., Wang, H. P. et al., A strategy for precise and large scale identification of core fucosylated glycoproteins. Mol. Cell. Proteomics 2009, 8, 913-923.
34. Dai, Z., Fan, J., Liu, Y., Zhou, J. et al., Identification and analysis of alpha1, 6-fucosylated proteins in human normal liver tissues by a target glycoproteomic approach. Electrophoresis 2007, 28, 4382-4391.
35. Ueda, K., Katagiri, T., Shimada, T., Irie, S. et al., Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer. J. Proteome Res. 2007, 6, 3475-3483.
36. Nakano, M., Nakagawa, T., Ito, T., Kitada, T. et al., Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers. Int. J. Cancer 2008, 122, 2301-2309.
37. Wang, D., Hincapie, M., Guergova-Kuras, M., Kadas, J. et al., Antigen identification and characterization of lung cancer specific monoclonal antibodies produced by mAb proteomics. J. Proteome Res. 2010, 9, 1834-1842.